Neurotoxin from Organism (Clostridium botulinum) Lyophilized Drug Product

ALLERGAN

Revision date : 2018-03-08

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2018-03-08

Product name

Neurotoxin from Organism (Clostridium botulinum) Lyophilized Drug Product

Product Synonyms

Botox

1.2.1 Relevant identified uses

Acetylcholine release inhibitor and Neuromuscular blocking agent for OAB, Prophylaxis of headaches in adults with chronic migraine, spasticity in adults, cervical dystonia in adults,

Manufacturer Name

ALLERGAN

Emergency telephone

Call CHEMTREC Day or Night

Icons in SDS

Company Information

company name

ALLERGAN

e-mail address of the competent person responsible for the Safety Data Sheet

SDS@Allergan.com

Section 2

2.1 Classification of the substance or mixture

OSHA Regulatory Status This chemical is not considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.122) Not a dangerous substance or mixture according to the Globally Harmonized System (GHS)

2.2 Label elements

Emergency Overview The product contains no substances which at their given concentration, are considered to be hazardous to health Appearance Dehydrated product Physical state Solid Odor No information available Contained in a Vial Chemical Name Symptoms Botulinum toxin type A The most common adverse reactions (≥5% and >placebo) are OAB urinary tract infection, dysuria, urinary retention; Detrusor Overactivity associated with a neurologic condition urinary tract infection, urinary retention; Chronic Migraine neck pain, headache; Spasticity pain in extremity; Cervical Dystonia dysphagia, upper respiratory infection, neck pain, headache, increased cough, flu syndrome, back pain, rhinitis; Axillary Hyperhidrosis: injection site pain and hemorrhage, non-axillary sweating, pharyngitis, flu syndrome Chemical Name

Medical Conditions Generally Aggravated by Exposure

Botulinum toxin type A Hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, Infection at the proposed injection site, Intradetrusor Injections: Urinary Tract Infection or Urinary Retention

Further information

Unknown Acute Toxicity 35.7% of the mixture consists of ingredient(s) of unknown toxicity Over the counter drugs in their solid form are considered exempt under the criteria of the Federal OSHA Hazard Communication Standard 20 CFR 1910.1200. However, in an industrial setting where a component's occupational exposure limit may be surpassed, than can be considered hazardous

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.